title: Thrombotic microangiopathy: eculizumab for atypical haemolytic uraemic syndrome: what next?
authors.affiliation: Department of Nephrology, Université de Nantes, 30 Boulevard Jean Monnet, France.
authors.forename: Fadi
authors.initials: F
authors.lastname: Fakhouri
authors.forename: Véronique
authors.initials: V
authors.lastname: Frémeaux-Bacchi
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D065766:Atypical Hemolytic Uremic Syndrome; D006463:Hemolytic-Uremic Syndrome / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D057049:Thrombotic Microangiopathies / Q000188:drug therapy* / Q000209:etiology; D016896:Treatment Outcome
chemical_list: D061067:Antibodies, Monoclonal, Humanized; C481642:eculizumab
references.citation: Nat Rev Nephrol. 2012 Nov;8(11):643-57
references.pmid: 23026949
references.citation: Clin J Am Soc Nephrol. 2013 Apr;8(4):554-62
references.pmid: 23307876
references.citation: Am J Transplant. 2013 Mar;13(3):663-75
references.pmid: 23356914
references.citation: N Engl J Med. 2013 Jun 6;368(23):2169-81
references.pmid: 23738544